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Extracellular vesicles represent a rich source of novel biomarkers in the diagnosis and prognosis of disease.
However, there is currently limited information elucidating the most efficient methods for obtaining high yields
of pure exosomes, a subset of extracellular vesicles, from cell culture supernatant and complex biological fluids
such as plasma. To this end, we comprehensively characterize a variety of exosome isolation protocols for their
efficiency, yield and purity of isolated exosomes. Repeated ultracentrifugation steps can reduce the quality of
exosome preparations leading to lower exosome yield. We show that concentration of cell culture conditioned
media using ultrafiltration devices results in increased vesicle isolation when compared to traditional
ultracentrifugation protocols. However, our data on using conditioned media isolated from the Non-Small-
Cell Lung Cancer (NSCLC) SK-MES-1 cell line demonstrates that the choice of concentrating device can
greatly impact the yield of isolated exosomes. We find that centrifuge-based concentrating methods are more
appropriate than pressure-driven concentrating devices and allow the rapid isolation of exosomes from both
NSCLC cell culture conditioned media and complex biological fluids. In fact to date, no protocol detailing
exosome isolation utilizing current commercial methods from both cells and patient samples has been described.
Utilizing tunable resistive pulse sensing and protein analysis, we provide a comparative analysis of 4 exosome
isolation techniques, indicating their efficacy and preparation purity. Our results demonstrate that current
precipitation protocols for the isolation of exosomes from cell culture conditioned media and plasma provide the
least pure preparations of exosomes, whereas size exclusion isolation is comparable to density gradient
purification of exosomes. We have identified current shortcomings in common extracellular vesicle isolation
methods and provide a potential standardized method that is effective, reproducible and can be utilized for
various starting materials. We believe this method will have extensive application in the growing field of
extracellular vesicle research.
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I
t has been recognized that critical components of
intercellular communication are small membrane
extracellular vesicles (EVs) (1,2). EVs are capable
of inducing local and systemic changes, thereby promot-
ing disease progression in a number of settings (3). The
functional impact of EVs is imparted by the molecular
components (e.g. protein and RNA cargo) they carry,
prompting the increased interest in EVs as potential novel
biomarkers for the diagnosis and prognosis of disease
progression (4).
A current problem impeding the advancement in
EV research is the lack of characterization of current
methodologies evaluating their usability, vesicle purity
and yield from cell culture conditioned media (CCM),
and complex biological fluids such as plasma. High-
throughput methods that minimize the co-isolation of
protein aggregates are essential to develop accurate
biomarker signatures for disease and assess the down-
stream biological impacts of EVs in recipient cells. The
current ‘‘gold standard’’ for the purification of a subset
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of EVs (known as exosomes) is differential centrifuga-
tion, which typically consists of low-speed centrifugation
to remove cells and large vesicles and high-speed ultra-
centrifugation to pellet exosomes (5). Density gradients
can then be utilized to remove contaminating impurities
such as non-specific argonaute proteins (6). Ultracentri-
fugation of large volumes of CCM can be cumbersome
and results in sample loss depending on the skill of
the operator. It has also been suggested in the literature
that repeated ultracentrifugation steps can damage vesi-
cles and reduce yields, thereby potentially impacting
proteomic and RNA analysis of exosome content (7).
An alternative to ultracentrifugation is concentration of
large volumes of CCM using ultrafiltration devices. Thus
we have developed an optimized protocol for exosome
isolation minimizing these issues.
In this study, we comprehensively detail tunable resistive
pulse sensing (TRPS)-based assessments of particle size
and concentration, in conjunction with protein analysis of
purified exosomes in order to assess isolation efficacy.
Using these analysis techniques, we address the impact
of repeated ultracentrifugation steps on vesicle yield
when compared to ultrafiltration of CCM. Our evaluation
of particle yield and purity compares and contrasts
4 methods, including 2 commercial products that have
not been assessed in the current literature: size exclusion
chromatography (SEC) using qEV columns, and density
gradient purification. Utilizing human plasma, we demon-
strate that isolation techniques vary greatly in their ability
to provide pure populations of exosomes. We find that
OptiPrepTM gradient isolation provides the highest pur-
ification of exosomes from CCM, but is comparable
to SEC when evaluating protein exosome markers. SEC
is also shown to be exceptional in purifying exosomes
from plasma and outperforms precipitation protocols
that heavily co-isolate contaminating plasma proteins.
This purity is essential for the comprehensive analysis of
exosomes as potential biomarkers.
Materials and methods
Cell culture
The SK-MES-1 cell line was used to isolate exosomes. This
cell line is an adherent human squamous Non-Small-Cell
Lung Cancer (NSCLC) cell line. SK-MES-1 cells were
obtained from ATCC, and authentication was carried
out in-house using short tandem repeat (STR) profiling.
Cells were maintained in Dulbecco’s minimal essential
medium (DMEM) supplemented with 10% foetal bovine
serum, 100 U/mL penicillin and 100 mg/mL streptomycin
and incubated at 378C in 5% CO2. Cells were grown to 70%
confluency, washed 3 times with PBS and incubated for
24 hours in serum free media. CCM was collected after
24 hours, and cell cultures were trypsinized and analyzed
for the presence of necrotic cells with trypan blue staining.
Plasma preparation
All plasma collection and preparation protocols were
approved by the QIMR Berghofer Human Ethics Committee
(P1499) and participants provided written, informed
consent. All plasma used in this investigation was obtained
from one individual. Twenty millilitres of blood was
obtained from a healthy volunteer in EDTA-coated tubes
and allowed to sit at room temperature for 30 minutes.
Whole blood was then centrifuged at 1,200 g for 10 minutes
at 48C to separate plasma. Plasma was transferred to a
clean tube and centrifuged again at 1,800 g for 10 minutes
at 48C before being aliquoted, snap frozen on dry ice
and stored at 808C until use.
Ultracentrifugation
CCM was harvested from SK-MES-1 cells and centrifuged
using a Beckman Coulter Allegra† X-15R centrifuge at
300 g at 48C for 10 minutes to remove detached cells.
Supernatant was collected and filtered through 0.22 mm
filters (Merck Millipore) to remove contaminating apop-
totic bodies, microvesicles and cell debris. Clarified CCM
was then centrifuged in a Beckman Coulter OptimaTM L-
80XP Ultracentrifuge at 100,000 gavg at 48C for 90 minutes
with a Type 50.2 Ti rotor (k-factor: 157.7) to pellet
exosomes. The supernatant was carefully removed, and
crude exosome-containing pellets were resuspended in
1 mL of ice-cold PBS and pooled. A second round of
ultracentrifugation [100,000 gavg at 48C for 90 minutes
with a Type 50.2 Ti rotor (k-factor: 157.7)] was carried out,
and the resulting exosome pellet resuspended in 500 mL
of PBS (Supplementary Fig. 1).
Ultrafiltration
Clarified CCM was prepared as described above and
concentrated to 500 mL using either pressure-driven or
centrifugation-based concentrating protocols (Supple-
mentary Fig. 2). Briefly, 150 mL of CCM was concentrated
to 5 mL in Stirred Cell Model 8200 with 100,000 kDa
Biomax polyethersulfone or Ultracel regenerated cellulose
membranes using nitrogen gas (10 psi). The 10 mL
concentrate was transferred to an Amicon† Ultra-15
100,000 kDa device and concentrated further to 500 mL
using an Allegra† X-15R centrifuge at 4,000 g at 48C.
After use, membranes were washed with gentle shaking in
either 30 mL 70% ethanol or 0.1 M NaOH for 5 minutes
and rinsed 3 times in PBS for 5 minutes. Alternatively,
150 mL of CCM was concentrated to 500 mL with
the Centricon Plus-70 Centrifugal Filter (Ultracel-PL
Membrane, 100 kDa) device using an Allegra† X-15R
centrifuge at 3,500 g at 48C. The concentrate was then
recovered with a reverse spin at 1,000 g for 2 minutes.
Centricon devices were washed with 30 mL 70% ethanol or
0.1 M NaOH by centrifugation at 3,500 g. Centricon
devices were then rinsed by centrifugation at 3,500 g
with 30 mL volumes of PBS (Supplementary Fig. 2).
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OptiPrepTM density gradient purification
Exosomes were purified using an OptiPrepTM density
gradient. Briefly, a discontinuous iodixanol gradient was
prepared by diluting a stock solution of OptiPrepTM
(60% w/v) with 0.25 M sucrose/10 mM Tris, pH 7.5 to
generate 40%, 20%, 10% and 5% w/v iodixanol solutions.
With care, the discontinuous iodixanol gradient was
generated by sequentially layering 3 mL each of 40,
20 and 10% (w/v) iodixanol solutions, followed by 2.5
mL of the 5% iodixanol solution in 1489 mm Ultra-
ClearTM Beckman Coulter centrifuge tubes. A 500 mL
volume of CCM containing 61011 particles was
overlaid on the discontinuous iodixanol gradient and
centrifuged using a SW 40 Ti rotor for 16 hours at
100,000 gavg (k-factor: 277.5) at 48C. Fractions of 1 mL
were collected from the top of the gradient and ana-
lyzed for particle concentration with TRPS. Positive
fractions (6 and 7) were diluted to 20 mL in PBS and
centrifuged at 100,000 gavg for 2 hours at 48C with a
Type 50.2 Ti rotor (k-factor: 157.7). The resulting pellets
were resuspended in 200 mL PBS.
ExoQuickTM precipitation
Exosome isolation from CCM
ExoQuickTM precipitation was carried out according to
manufacturer’s instructions (System Biosciences). Briefly,
500 mL of clarified CCM was diluted to 5 mL in PBS and
mixed with 1 mL of ExoQuick-TCTM solution by inverting
the tube several times. The sample was incubated over-
night at 48C then centrifuged twice at 1,500 g for 30 and
5 minutes, respectively, in order to remove the superna-
tant. The supernatant was discarded, and the pellet was
resuspended in 200 mL of PBS.
Exosome isolation from human plasma
Plasma was thawed on ice and centrifuged at 1,500 g for
10 minutes at 48C. The supernatant was removed, and
large vesicles were removed with another centrifugation
step at 10,000 g for 20 minutes at 48C. The supernatant was
transferred to a new tube, and 2.5 mL of Thrombin (System
Bioscience, TMEXO-1) was added to 250 mL of plasma
and incubated for 5 minutes at room temperature to
remove fibrinogen. The plasma was then centrifuged at
10,000 g for 5 minutes, and the supernatant was collected.
The plasma was then incubated with ExoQuickTM for
60 minutes at 48C. The ExoQuickTM/plasma sample was
then centrifuged twice at 1,500 g for 30 and 5 minutes,
respectively, in order to remove the supernatant. The pellet
was resuspended in 200 mL of PBS and filtered through
an Ultrafree† 0.22 mm centrifugal filter device (Merck
Millipore) to remove any large contaminating vesicles.
Exo-spinTM precipitation
Exosome isolation from CCM
Exo-spinTM precipitation was carried out according to
manufacturer’s instructions (Cell Guidance Systems).
Briefly, 250 mL of precipitation buffer was mixed with
500 mL of clarified CCM and incubated overnight at 48C.
The sample was then spun at 20,000 g for 30 minutes and
the supernatant was discarded; the pellet was then
resuspended in 100 mL of PBS. The sample was further
purified using the provided columns, and exosomes were
eluted in 200 mL of PBS.
Exosome isolation from human plasma
For the isolation of exosomes from human plasma, 250 mL
of plasma was thawed on ice and prepared by removing
platelets and large vesicles by spinning at 1,500 g and
10,000 g for 10 and 20 minutes, respectively. Two-hundred
microlitres of prepared plasmawas then mixed with 100 mL
of precipitation reagent and incubated at 48C for 5 minutes
before pelleting exosomes at 20,000 g for 30 minutes. The
supernatant was removed, and the exosome-containing
pellet resuspended in 100 mL of PBS and purified on
columns as before. The 200 mL exosome preparation was
further filtered through an Ultrafree† 0.22 mm centrifugal
filter device to remove any large contaminating vesicles.
Size exclusion purification
Five-hundred microlitres of clarified CCM, or 1 mL of
processed plasma (centrifuged at 1,500 g and 10,000 g
for 10 and 20 minutes, respectively) was overlaid on qEV
size exclusion columns (Izon) followed by elution with
PBS. Five-hundred-microlitre fractions were collected,
and particle and protein concentrations determined with
TRPS and the Bradford assay (Bio-Rad), respectively
(Supplementary Fig. 3). High particle/low protein fractions
from CCM were pooled and concentrated in Amicon†
Ultra-4 10 kDa nominal molecular weight centrifugal
filter units to a final volume of 200 mL. Fractions from
plasma were pooled and filtered with an Ultrafree† 0.22 mm
centrifugal filter device before being concentrated in an
Amicon† Ultra-4 10 kDa device.
Tunable resistive pulse sensing
The concentration and size distribution of particles was
analyzed with TRPS (qNano, Izon Science Ltd) using a
NP100 nanopore at a 45 mm stretch. The concentration
of particles was standardized using multi-pressure cali-
bration with 70 nm carboxylated polystyrene beads at
a concentration of 1.51011 particles/mL.
Electron microscopy
Exosomes were visualized using transmission electron
microscopy (TEM) according to Thery et al. (5). Briefly,
3 mL of exosome suspension was fixed in 50100 mL of 2%
paraformaldehyde. Two microlitres of this mix was trans-
ferred onto each of 2 Formvar-carbon coated electron
microscopygrids. Membranes were covered for 20 minutes.
A 100 mL drop of PBS was placed on a sheet of parafilm
and grids transferred with the sample membrane side
facing down using clean forceps for 2 minutes. The grids
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were kept wet on the side of the membrane during all steps,
but dry on the opposite side. The grids were transferred
to a 50 mL drop of 1% glutaraldehyde for 5 minutes
before transferring to a 100 mL drop of distilled water
for 2 minutes. This was repeated 7 times for a total of
8 water washes. To contrast the samples, grids were
transferred to a 50 mL drop of uranyl-oxalate solution,
pH 7, for 5 minutes before transferring to a 50 mL drop
of methyl-cellulose-UA (a mixture of 4% uranyl acetate
and 2% methyl cellulose in a ratio of 100 mL/900 mL,
respectively) for 10 minutes, placing the grids on a glass
dish covered with parafilm on ice. The grids were removed
with stainless steel loops and excess fluid blotted gently
on Whatman no.1 filter paper. Grids were left to dry
and stored in appropriate grid storage boxes. Grids were
observed with JEM 1,011 transmission electron micro-
scope at 80 kV.
Antibodies and reagents
qEV columns were purchased from Izon and stored in PBS
(0.1% sodium azide) at 48C. Exo-SpinTM and ExoQuickTM
kits for blood and cell culture were purchased from Cell
Guidance Systems and System Bioscience, respectively,
and stored at 48C until use. OptiPrepTM was purchased
from Sigma-Aldrich. The following antibodies were used
for Western blotting: TSG101 (Santa Cruz, sc-6037),
CD63 (Abcam, ab8219), Flotillin-1 (BD Transduction
Laboratories, 610821), HSP70 (Transduction Labora-
tories, 610608), Calnexin (Cell Signaling Technology,
2679S) and Albumin (Cell Signaling Technology, 4929S).
Horseradish peroxidase (HRP)-conjugated secondary
antibodies were purchased from Thermo Scientific.
Western blot analysis
Western blots were performed as previously described (8,9).
Briefly, exosome isolations were lysed in reducing sample
buffer [0.25 M TrisHCl (pH 6.8), 40% glycerol, 8% SDS,
5% 2-mercaptoethanol and 0.04% bromophenol blue] or
non-reducing sample buffer (without 2-mercaptoethanol)
and boiled for 10 minutes at 958C. Proteins were resolved
by SDS-PAGE (SDS-polyacrylamide gel electrophoresis),
transferred to polyvinylidene fluoride membranes, blocked
in 5% non-fat powdered milk in PBS-T (0.5% Tween-20)
and probed with antibodies. All proteins were resolved
under fully denaturing and reducing conditions, apart
from CD63, which was resolved under non-reducing
conditions. Protein bands were detected using X-ray film
and enhanced chemiluminescence reagent (Amersham
ECL Select).
Statistical methods
Statistical analyses were performed using Student’s t-test
and one-way analysis of variance. All experiments were
performed as a minimum of 3 independent repeats.
Differences with p-values less than 0.05 were considered
significant (*pB0.05, **pB0.001, ***pB0.0001).
Results
SK-MES-1 cells secrete exosomes
The identification of particles as exosomes relies on
various criteria. Exosomes range in size from 50 to 100
nm (8), they display a cup-shaped morphology by EM,
and proteomic analysis reveals the presence of common
proteins (911). Figure 1a demonstrates the presence
of canonical exosome proteins and the absence of the
Fig. 1. The NSCLC SK-MES-1 cell line produces exosomes that can be isolated with ultrafiltration of CCM. (a) 5 mg of protein
was used for Western blot analysis of isolated exosomes. The presence of canonical exosome proteins, and the absence of Calnexin
demonstrates a pure exosome preparation. (b) TRPS analysis demonstrates a size distribution of particles consistent with the
size range of exosomes. (c) EM image of exosomes demonstrates cup-shape morphology, size bar200 nm. CL: cell lysate;
E: exosome lysate.
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endoplasmic reticulum protein Calnexin from exosomes
isolated using the ultrafiltration protocol (Supplementary
Fig. 1). Furthermore, isolated particles exhibit expected
morphology and size profiles consistent with pure exo-
some preparations (Fig. 1b and c).
Centrifugal concentration provides optimal particle
yield from CCM
Currently, the main protein concentrating devices available
are either pressure-driven (Stirred Cell) or centrifugation-
based (Centricon). In order to investigate if there are dif-
ferences in exosome yield between the 2 methods, we
compared the Stirred Cell using a cellulose or biomax mem-
brane with Centricon protein concentrators. Interestingly,
using the Stirred Cell, both cellulose and biomax membranes
recovered less particles than the Centricon device, which
had an approximate 3-fold greater yield (Fig. 2a). This was
also seen when the abundance of the canonical exosome
protein Flotillin-1 (9,10) was assessed (Fig. 2b). When
membranes were restored with sodium hydroxide, particle
yield remained low in the Stirred Cell concentration work-
flow, with no impact on the yield from the Centricon (Fig. 2b).
However, when the membranes were washed thoroughly
with ethanol and PBS, the yield from the Stirred Cell
increased to levels comparable to the Centricon (Fig. 2c).
These data indicated that the Centricon method is superior
in concentrating exosomes and that Stirred Cell mem-
branes non-specifically bind a significant amount of
exosomes.
Ultrafiltration is a faster alternative to
ultracentrifugation
To investigate the exact differences between ultracentrifu-
gation and ultrafiltration on exosome yield and quality,
we used a combination of particle analysis and protein
assessment of positive markers. Particle tracking using
TRPS showed that both ultracentrifugation and ultrafil-
tration isolated particles ranging in size from 50 to 250 nm
(Fig. 3a), with no difference observed in the percentage
makeup of populations with defined size ranges (Fig. 3b).
Interestingly, ultrafiltration resulted in the highest
recovery of particles B100 nm compared to ultracentri-
fugation (Fig. 3c). Analysis of equal volumes of exosome
preparations for HSP70 and Flotillin-1 was not sensitive
enough to detect a higher ratio of exosomes between the
2 preparation methods; however, TSG101 expression was
increased slightly in the ultrafiltration sample (Fig. 3d).
Both methods were therefore comparable in recover-
ing exosomes, yet ultrafiltration was far more time
efficient taking only 20 minutes to concentrate 150 mL
of CCM compared to 2 rounds of ultracentrifugation
for 90 minutes each.
Fig. 2. The choice of concentrating method impacts on particle recovery. (a) Significant reduction in the yield of B100 nm particles was
observed with the first run of a membrane using the pressure-driven concentrating Stirred Cell device, but not the centrifuge-based
Centricon device. (b) Particle yield from membranes restored with NaOH remained low with the Stirred Cell, but was not altered with
the Centricon concentrator. (c) B100 nm particle yield from the Stirred Cell was comparable to Centricon concentration when
membranes were washed with ethanol. n39SEM, ***pB0.001. SC: Stirred Cell.
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Repeated ultracentrifugation reduces particle yield
and recovery
Next, we examined if repeated ultracentrifugation rounds
would reduce the quality and recovery of exosomes
purified with a density gradient. Interestingly, ultracen-
trifugation consistently resulted in significantly higher
particle concentrations in fractions 810 (pB0.05)
compared to exosomes prepared by ultrafiltration of
CCM, suggesting that the different preparative methods
altered particle characteristics (Fig. 4a). This increase
in particle concentration at higher densities for ultracen-
trifugation was accompanied with an increase in the
membrane protein Flotillin-1, but not TSG101, poten-
tially indicating ruptured membranes (Supplementary
Fig. 4). Positive protein markers for exosomes overlap
in fractions 6 and 7, and these fractions were pooled
and ultracentrifuged at 100,000 g for 2 hours to pellet
exosomes for further analysis. Both ultracentrifugation
and ultrafiltration before OptiPrepTM did not alter the
size distribution, or morphology of purified exosomes
(Fig. 4d and e). However, ultrafiltration preparations
would consistently produce significantly higher particle
yields (Fig. 4b), a result that was accompanied by a
higher percentage recovery when total particles from
fraction 6 and 7 were compared to total particles
recovered (Fig. 4c).
The choice of isolation method impacts on particle
concentration and protein yield
Exosomes were prepared from concentrated CCM of
SK-MES-1 cells using 4 different isolation techniques.
With the recent increased interest in EV research, there
have been numerous commercial products being developed
for the rapid isolation of exosomes. We compared 3
commercially available products: ExoQuickTM, Exo-spinTM
and Izon qEV columns with OptiPrepTM density gradient
prepared exosomes. All 3 commercial products provided
very similar size distribution profiles and morphology
(Fig. 5a), the only difference being the presence of particles
200 nm when compared to density gradient exosome
preparations (Fig. 5a and d). ExoQuickTM and Exo-spinTM
produced significantly higher yields of B100 nm particles
compared to qEV and density gradient isolation techni-
ques (Fig. 5b). By contrast, when particles are expressed
per mg of protein (a good indicator of particle purity (12)),
ExoQuickTM is shown to perform poorly, suggesting the
co-isolation of contaminating proteins (Fig. 5c). Exo-spinTM
performed significantly better compared to ExoQuickTM,
but both qEV and density gradient are the superior
isolation techniques (Fig. 5c). Although there is a potential
that precipitation protocols co-isolate a higher percentage
of larger particles, we do not find this (Fig. 5d), largely
due to the preparation of CCM with a 0.22 mm filtra-
tion step. The absence of larger particles is further
validated with a larger nanopore (Supplementary Fig. 5).
The increased ratio of particles per mg of protein seen
with qEV columns compared to density gradient purifica-
tion is most likely due to the loss of particles associated
with density gradient purification (Fig. 4a). When select-
ing purely on size this loss is avoided, providing higher
recovery of particles B100 nm in size.
Fig. 3. Ultrafiltration recovers more particles compared to ultracentrifugation. (a) Size distribution of particles before density gradient
purification. (b) Percentage of particle size ranges from ultracentrifugation and ultrafiltration isolations. (c) Ultrafiltration was shown
to significantly increase the recovery of B100 nm particles compared to ultracentrifugation; n39SEM, *pB0.05. (d) Western blot
analysis of equal volumes from ultracentrifugation and ultrafiltration did not show a large difference in protein markers for exosomes.
UC: ultracentrifugation; UF: ultrafiltration.
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Density gradient and qEV samples are enriched for
exosome markers
In order to validate the use of particles per mg of pro-
tein ratio as a measure of isolation efficacy, we assessed
specific protein content by Western blot. We analyzed
exosome markers using 10 mg of protein from each
isolation method and found elevated levels of exosomal
markers HSP70, Flotillin-1 and TSG101 in qEV and density
gradient lysates compared to ExoQuickTM and Exo-spinTM
(Fig. 5e). This further supports the idea that current
precipitation techniques perform poorly in providing pure
exosome preparations. Exo-spinTM yielded higher levels of
exosome markers compared to ExoQuickTM, indicating
the importance of a post-precipitation purification step.
Fig. 4. Ultrafiltration of CCM results in higher recovery of particles after density gradient purification. (a) Particle analysis of 1 mL
fractions collected from density gradient. Ultracentrifugation results in a significantly higher proportion of particles at higher densities
in fractions 810. (b) Total particles (B100 nm) isolated from ultracentrifugation and ultrafiltration. Ultrafiltration of CCM before
density gradient purification results in a higher yield of B100 nm particles compared to ultracentrifugation preparation. (c) Percentage
recovery of particles collected from fraction 6 and 7 is higher with the ultrafiltration protocol compared to ultracentrifugation. (d)
Size distribution of particles isolated from both protocols indicates no difference in size profile of particles isolated. (e) EM images
of exosomes isolated with ultracentrifugation and ultrafiltration protocols, size bar200 nm. n39SEM, *pB0.05. UC:
ultracentrifugation; UF: ultrafiltration.
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In conclusion, both ExoQuickTM and Exo-spinTM have
significantly more non-exosomal protein contamination
as evidenced by the particle/protein ratio combined with
increased exosome marker expression in qEV and density
gradient isolations (Fig. 5).
SEC outperforms precipitation of exosomes isolated
from human plasma
In order to assess the utility of these techniques on
the isolation of exosomes from human bodily fluids, we
isolated exosomes from normal human plasma using
ExoQuickTM, Exo-spinTM and qEV columns. Density gra-
dient purification has been shown to provide the most
pure exosome preparation from plasma (13); however,
due to the often-limited sample availability of plasma,
we decided to assess techniques that would not require
more than 1 mL of plasma. All 3 methods isolate particles
with a size range equivalent to exosomes (Fig. 6a), but
recovery of particles from plasma is dependent on the
isolation process (Fig. 6b). At a low purity level, both
precipitation protocols recover the majority of particles
in relation to unprocessed plasma (Fig. 6b). The SEC
method using qEV columns provided the lowest exosome
recovery rate (Fig. 6b), but with the highest purity, based
on the selective inclusion of eluted fractions. Similar to the
isolation of exosomes from CCM, when the concentration
of particles is expressed relative to protein concentration,
ExoQuickTM performs very poorly (Fig. 6c). Exo-spinTM
provides a significantly higher purification compared to
ExoQuickTM, but column purification alone provides the
highest degree of purification (Fig. 6c). This is supported
by EM, and Western blot analysis of 50 mg of protein. EM
images indicate a high degree of contamination in exosome
isolations (Fig. 6a), and Flotillin-1 was only detectable in
the samples isolated with qEV technique (Fig. 6d). This
was further accompanied with a high degree of albumin
contamination in the ExoQuickTM and Exo-spinTM that was
not present in the qEV isolation (Fig. 6d).
Discussion
EVs, including exosomes, are present in human biofluids
such as plasma (1,14,15). As such, they can potentially
serve as a source of novel biomarkers in the diagnosis and
prognosis of diseases such as cancer or infectious diseases.
As yet, the scientific community has not yet fully taken
advantage of EVs which may be due to a lack of a
standardized purification method. Although differential
centrifugation coupled to ultracentrifugation has been the
most widely adopted of methods, the impacts of repeated
ultracentrifugation steps on the recovery of exosome yields
has not been fully assessed. Ultracentrifugation is also not
always applicable to clinical samples due to the volume
of required starting material and the low throughput of
this method. Moreover, standardization of purification
protocols from CCM and biological fluids is necessary as
disparate techniques impact on downstream protein and
RNA profiling (16). To this end, new rapid isolation
protocols were assessed for yield and purity in order to
standardize and optimize exosome purification protocols
from CCM and human plasma.
Fig. 5. Alternative rapid isolation techniques of exosomes from concentrated media. (a) Size distribution and EM images of particles
isolated from precipitation methods and qEV SEC columns, size bar200 nm. (b) Precipitation methods isolate significantly more
particles (B100 nm) compared to SEC and density gradient purification. (c) Concentration of particles expressed as a ratio per
microgram of protein. Both SEC and DG provide superior purity as illustrated by significantly more particles per microgram of protein
compared to precipitation protocols. (d) No difference was observed in the particle size composition of different isolation methods.
(e) Western blot analysis of 10 mg of protein from each protocol. Exosome-positive markers were enriched in qEV and DG lysates
compared to precipitation isolations, and all isolation techniques were absent for Calnexin, which was present only in the cell lystate
fraction. n39SEM, *pB0.05, **pB0.01, ***pB0.001. CL: cell lysate; EQ: ExoQuickTM; ES: Exo-spinTM; qEV: size exclusion
columns; DG: density gradient.
Richard J. Lobb et al.
8
(page number not for citation purpose)
Citation: Journal of Extracellular Vesicles 2015, 4: 27031 - http://dx.doi.org/10.3402/jev.v4.27031
Ultracentrifugation is the most widely used exosome
purification protocol and has long been considered the
gold standard for isolation of relatively homogenous size
populations of exosomes (3,17,18). However, this process
is lengthy and often results in variable recovery rates due
to differences among researchers using different rotor
types (19). Further, repeated ultracentrifugation steps
may damage isolated vesicles, reducing their quality. We
show that ultrafiltration is capable of isolating exosomes
(Fig. 1), and provides a higher particle yield compared to
ultracentrifugation, thereby increasing exosome yield and
isolation efficiency (Fig. 3). The increased yield of particle
concentration is also coupled to a shorter processing time,
thereby increasing the efficiency of sample throughput.
This supports previous research that indicates that con-
centration methods are more suitable for producing
clinical grade exosomes in time efficiency and quality
compared to the classical ultracentrifugation protocol (7).
Ultrafiltration is a powerful tool in optimizing exosome
isolations, yet it was unclear what concentrating methods
are most appropriate for exosome isolations. Particle yield
can be dramatically low in pressure-driven concentrating
devices compared to centrifuge concentrating devices
(Fig. 2). Non-specific absorption to both cellulose and
biomax membranes of the Stirred Cell causes this reduction.
However, once the membrane has been sufficiently
‘‘blocked’’ with exosome particles, the yield from CCM
is comparable to the Centricon. This is supported with
washing the membranes with ethanol or sodium hydro-
xide. When the membrane was fully restored with sodium
hydroxide, particle yield would remain low; however, an
ethanol wash resulted in maximized particle yield (Fig. 2).
This is most likely due to the large surface area (28.7 cm2),
and contact time with the membrane of the Stirred Cell.
This loss of particles does not occur with Centricons due
to the lower surface area of the membrane (19 cm2),
and a reverse centrifugation step allowing particles to be
spun off the membrane. Given this, when working with
volumes of 50200 mL of conditioned media, a centrifuge-
based concentrator is the most appropriate device.
Some applications may require the use of larger volumes
of CCM. We found that pressure-driven concentrating
is more appropriate with volumes in excess of 400 mL due
to the higher flow rate, and that exosome loss is only
observed with the first 50100 mL of CCM.
Previous studies on comparing exosome isolation
techniques have been carried out (6,13,20), but there is
limited information regarding recent precipitation-based
isolation techniques. In addition to updating the analysis
of these techniques, we compared preparation efficacy
Fig. 6. Exosomes isolated from plasma. (a) Size distribution profiles and EM images indicated all 3 protocols isolated particles of the
correct size, size bar200 nm. (b) Percentage recovery of particles in relation to unprocessed plasma showed no difference between EQ,
ES and qEV. (c) Particle/protein ratio indicated that SEC using qEV columns significantly outperformed both EQ and ES. (d) Western
blot analysis of 50 mg of protein indicated that all 3 methods were absent for Calnexin; however, Flotillin-1 could only be detected in the
qEV lysate. The presence of non-exosomal contaminating proteins in EQ and ES samples was demonstrated with the abundance of
albumin, which was almost absent in the qEV sample. n39SEM, **pB0.01, ***pB0.001. CL: cell lysate; EQ: ExoQuickTM; ES:
Exo-spinTM; qEV: size exclusion columns.
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utilizing the NSCLC cell line SK-MES-1 for yield. Density
gradient purification is a technique repeatedly shown to
provide the highest degree of purity (6,12,13). Interest-
ingly, separation of particles with a density gradient
revealed a large abundance of particles in lower density
fractions, particularly fractions 35 (Fig. 4), demonstrat-
ing a heterogeneity of particles among exosome prepara-
tions. This heterogeneity has been described by others (21),
showing the presence of particles with different structural
and biochemical features due to different mechanisms
of biogenesis. Importantly, it should be recognized that
ExoQuickTM, Exo-spinTM and qEV are unable to resolve
this particle heterogeneity, leading to the isolation of non-
exosomal particles.
For the determination of an isolation method that
delivers the purest exosome isolation, the combination of
both particle and protein concentration analysis is re-
quired as either alone is insufficient to determine the
overall performance of an isolation technique. All meth-
ods (ExoQuickTM, Exo-spinTM, qEV and density gradient)
were shown to isolate exosomes from CCM as indicated by
EM, size profiling using TRPS and Western blot analysis.
The importance of using both particle and protein con-
centration is indicated as precipitation protocols produced
the highest yield of particles, yet had the lowest ratio
of particles to protein, potentially due to co-isolation of
contaminants (Fig. 5b and c). It is a possibility that high
particle low protein measurements could be attained if
exosomes were damaged during the isolation protocol and
lost some protein cargo. However, given that qEV columns
provided the highest number of particles per mg of protein,
it is unlikely this is happening to any large degree due to
the relatively ‘‘gentle’’ nature of this isolation method. To
further support this, Western blot analysis demonstrated
that qEV and density gradient fractions were enriched
for exosomal markers, and to a lesser degree Exo-spinTM,
whereas ExoQuickTM-based isolations demonstrated lower
enrichment of exosomal markers (Fig. 5e). A key message
from these data is that protein concentration is not a good
measure of exosome yield, and though common organelle
markers such as Calnexin are used to assess purity of
exosomes they are insufficient to indicate that isolation
techniques are devoid of contaminates.
The utility of all exosome isolation methods are
dependent on their performance when applied to human
clinical samples, particularly when the focus of exosomes
as novel biomarkers is being considered. Modern pre-
cipitation protocols have been purported as alternative
methods to ultracentrifugation because they require very
little starting sample from human biofluids combined
with high-throughput options. Isolating exosomes from
plasma is further complicated due to viscosity and density
issues (5,22), thereby limiting the purity obtained from
ultracentrifugation protocols. Recently, a single-step SEC
isolation of exosomes from human plasma has been
described (23). Using a similar approach, we find similar
results in the efficiency of qEV SEC columns to separate
exosome vesicles from contaminating plasma proteins.
SEC, however, does not concentrate samples and therefore
requires a second step. Instead of pelleting exosomes
with an ultracentrifugation step, we used protein concen-
trating devices to rapidly concentrate exosomal fractions.
This provides an efficient means of isolating and concen-
trating exosomes from human plasma, while avoiding
ultracentrifugation (Fig. 6). SEC purification using qEV
columns significantly outperformed both precipitation
protocols when the particle protein ratio was considered
(Fig. 6). This is also supported by analysis of Flotillin-1.
Flotillin-1 could not be detected in both precipitation
protocols but was present in the SEC isolation samples.
Furthermore, the purity of exosome isolations is impor-
tant and can be classified through a number of methods,
including the presence of contaminating extracellular
proteins (24). Though no contaminating extracellular
protein is shown in the in vitro precipitation isolations,
Fig. 6d demonstrates the high abundance of contaminat-
ing albumin with the precipitation methods from human
plasma compared to qEV columns. This furthers the
assumption that precipitation protocols are prone to heavy
contamination with plasma proteins and are therefore
limited in their utility for proteomic analysis of exosomes
from human plasma.
Isolation techniques that have been well characterized
are crucial for the analysis of exosomes as biomarkers. In
conclusion, we have investigated the influence of repeated
ultracentrifugation of CCM on the integrity of exosomes
and found that it is detrimental to achieve the highest
recovery of particles. Modern ultrafiltration devices pro-
vide a more rapid and overall higher yield of exosomes
when compared to ultracentrifugation. The steps of dif-
ferential centrifugation also have an impact on the input
before density gradient purification (19,25), a problem
that may bias subsequent analysis that ultrafiltration
avoids. Therefore, adoption of concentrating protocols
will provide improved analysis of exosomes. We show that
ultrafiltration coupled with SEC is a method that provides
particle purity comparable to density gradient purifica-
tion and is applicable to isolating a high yield of exosomes
from CCM and human plasma in an efficient time frame.
These data should inform the community in developing
optimal techniques for exosome extraction and research.
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